𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Small molecule inhibitors of Aβ-aggregation and neurotoxicity

✍ Scribed by Cheryl A. Hawkes; Vivian Ng; JoAnne McLaurin


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
211 KB
Volume
70
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Alzheimer disease (AD) is characterized pathologically by extracellular amyloid deposits composed of Aβ peptide, neurofibrillary tangles (NFTs) made up of hyperphosphorylated tau, and a deficit of cholinergic neurons in the basal forebrain. Presently, only symptomatic therapies are available for the treatment of AD and these therapies have a limited time frame of utility. Amyloid disorders represent the effects of chronic Aβ production and are not a secondary pathological effect caused by a distant trigger; therefore targeting Aβ is a viable pursuit. In this review, we will discuss the various small molecule anti‐aggregation inhibitors that have been reported in the literature, with emphasis on compounds that are presently being investigated in clinical trials. Drug Dev Res 70, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Small Molecule Inhibitors of Plasma Kall
✍ Wendy B. Young; Roopa Rai; William D. Shrader; Jana Burgess-Henry; Huiyong Hu; K 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views
Inhibition of β-Amyloid Aggregation and
✍ Jonathan R. Heal; Gareth W. Roberts; Gary Christie; Andrew D. Miller 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Complementary peptides are coded for by the nucleotide sequence (read 5' 33') of the complementary strand of DNA. By reading the sequence of complementary DNA in the 3' 35' direction, alternative complementary peptides may be derived. We describe the derivation, testing and analysis of six complemen

Non-peptidic Small Molecule Inhibitors o
✍ Cheol-Min Park; Chaohong Sun; Edward T. Olejniczak; Alan E. Wilson; Robert P. Me 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views